377. Closing the Gap in Clostridioides difficile Infection Prevention: An EHR Driven Approach to Oral Vancomycin Optimization

TL;DR

This study evaluated an EHR-based order set to improve vancomycin use for preventing CDI recurrence, finding better adherence to protocols but no significant increase in usage.

Contribution

Implementation of an EHR order set to standardize oral vancomycin prophylaxis for CDI prevention.

Findings

OVP prescribing rates did not significantly change before and after the order set implementation.

Adherence to OVP frequency improved significantly in the post-intervention group.

Fewer CDI breakthroughs and shorter hospital stays were observed after the order set was introduced.

Abstract

Systemic antibiotics significantly increase the risk of Clostridioides difficile infection (CDI) recurrence, particularly within the first 2-4 months following an initial episode. Studies have demonstrated that low-dose oral vancomycin prophylaxis (OVP) reduces CDI recurrence in these patients. Although OVP is recommended in our institution protocol, adherence has been inconsistent. To improve OVP prescribing, we implemented an electronic health record (EHR) embedded CDI prophylaxis order set.

This single-center, quasi-experimental, performance improvement project evaluated adults prescribed systemic antibiotics with a positive Clostridioides difficile PCR or toxin test within the past 12 months. The primary outcome was OVP prescribing rate pre- and post- order set implementation. Secondary outcomes included adherence to institutional protocol, rates of CDI breakthrough or recurrence, systemic antibiotic duration, and length of stay (LOS).

A total of 204 patients were included, with 155 in the pre-intervention group and 49 in the post-order set group, (table 1). OVP prescribing rates were similar between groups (34.2% vs 24.5%, P= 0.178). Among patients who received OVP with systemic antibiotics, adherence to institutional protocol for OVP frequency significantly improved in the post- order set group compared to the pre-intervention group (100% vs 45.3%, P=0.002). Breakthrough CDI occurred in 4 patients pre-intervention and 1 patient post-intervention, while recurrent CDI within 2 months occurred in 2 and 0 patients, respectively. Median LOS decreased from 14 to 8 days (P= 0.002), and median systemic antibiotic duration decreased from 10 to 6 days (P= 0.013) in the pre-intervention group and the post-order set group, respectively, (table 2).

Implementation of an EHR embedded CDI prophylaxis order set did not increase OVP prescribing rates but successfully standardized prescribing practices. Introducing an EHR best-practice advisory (BPA) is the next step to further enhance OVP utilization in patients with a history of CDI receiving systemic antibiotics.

All Authors: No reported disclosures

Figures